Microbial Limits Testing

This test provides an estimation of total aerobic bacteria and yeasts/molds and absence of designated microbial species in all types of pharmaceutical articles from raw materials to finished products following USP 61 and USP 62.

USP 2021 and 2022 assays

Related to the microbial limits test, iuvo is able to perform the USP 2021 and 2022 assays, which outline a similar procedure for nutritional and dietary supplements.  All assays result in the determination of the total aerobic bacterial and yeast/mold counts, as well as the absence of specific organisms identified as objectionable for each group of test articles.

Contact Us Today

If you’re seeking comprehensive medical device services, look no further than iuvo Bioscience. Our experienced team is ready to assist you with testing, evaluation, and regulatory support to ensure successful commercialization of your medical device. Contact us today to discuss your project and learn how our expertise can help you get to market fast.